Company Profile

Targeted Therapeutic Solutions LLC (AKA: TTS)
Profile last edited on: 6/29/15      CAGE: 6LDD2      UEI:

Business Identifier: Anticoagulant therapy
Year Founded
2011
First Award
2013
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3160 Chestnut Street Suite 200
Philadelphia, PA 19104
   (267)-294-5164
   N/A
   N/A
Location: Single
Congr. District: 03
County: Philadelphia

Public Profile

Targeted Therapeutic Solutions LLC ("TTS"), is developing a unique agent that can potentially reduce the incidence of stroke and its associated maladies. This therapeutic approach has the potential for reducing bleeding risk than existing clinical agents, making this technology useful for patients with or at risk for pulmonary embolism, deep vein thrombosis and certain types of heart attacks.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 1 NIH $239,505
Project Title: Development of a First-In-Class Targeted Fibrinolytic for Post-Surgical Thrombopr

Key People / Management

  Ronald Carnemolla

Company News

There are no news available.